Major Update 2: Remdesivir for Adults With COVID-19: A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points | Zendy

Anjum S. Kaka | Zendy; Roderick MacDonald | Zendy; Eric J. Linskens | Zendy; Lisa Langsetmo | Zendy; Kathryn Vela | Zendy; Wei DuanPorter | Zendy; Timothy J Wilt | Zendy

Open Access

Major Update 2: Remdesivir for Adults With COVID-19: A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points

Author(s) -

Anjum S. Kaka,

Roderick MacDonald,

Eric J. Linskens,

Lisa Langsetmo,

Kathryn Vela,

Wei DuanPorter,

Timothy J Wilt

Publication year - 2022

Publication title -

annals of internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.839

H-Index - 390

eISSN - 1539-3704

pISSN - 0003-4819

DOI - 10.7326/m21-4784

Subject(s) - medicine , randomized controlled trial , data extraction , medline , covid-19 , meta analysis , cochrane library , grading (engineering) , placebo , systematic review , emergency medicine , alternative medicine , civil engineering , disease , pathology , political science , infectious disease (medical specialty) , law , engineering

Remdesivir is approved for the treatment of adults hospitalized with COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research